8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jul 17, 2023 · 2y ago · Accession 0001140361-23-034684
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Jul 17, 2023
- Report date
- Jul 17, 2023
- Document
- brhc20055953_8k.htm
- Size
- 4.0 MB